Suppressive Antibiotic Therapy After Debridement, Antibiotics, and Implant Retention is Well-Tolerated Without Inducing Resistance: A Multicenter Study
The Journal of Arthroplasty · 2024
DOI: 10.1016/j.arth.2023.09.004 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Arthroplasty, 2024. Verfasst von Sumon Nandi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Prosthesis-Related Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Suppressive antibiotic therapy (SAT) after total joint arthroplasty (TJA) debridement, antibiotics, and implant retention (DAIR) maximizes reoperation-free survival. We evaluated SAT after DAIR of acutely infected primary TJA regarding: 1) adverse drug reaction (ADR)/intolerance; 2) reoperation for infection; and 3) antibiotic resistance. METHODS: Patients who underwent total knee arthroplasty (TKA) or total hip arthroplasty (THA) DAIR for acute periprosthetic joint infection at two academic medical centers from 2015 to 2020 were identified (n = 115). Data were collected on patient demographics, infecting organisms, antibiotics, ADR/intolerances, reoperations, and antibiotic resistances. Median SAT duration was 11 months. Stepwise multivariate logistic regressions were used to identify covariates significantly associated with outcomes of interest. RESULTS: There were 11.1 and 16.3% of TKA and THA DAIR patients, respectively, who had ADR/intolerance to SAT. Patients prescribed trimethoprim/sulfamethoxazole (P = .0014) or combination antibiotic therapy (P = .0169) after TKA DAIR had increased risk of ADR/intolerance. There was no difference in reoperation-free survival between TKA (83.3%) and THA (65.1%) DAIR (P = .5900) at mean 2.8-year follow-up. Risk of reoperation for infection was higher among TKA Staphylococcus aureus infections (P = .0004) and lower with increased SAT duration (P < .0450). The optimal duration of SAT was nearly 2 years. No cases of antibiotic resistance developed due to SAT. CONCLUSIONS: Consider SAT after TJA DAIR due to improved reoperation-free survival and favorable safety profile. Prolonged SAT did not induce antibiotic resistance. Use trimethoprim/sulfamethoxazole with caution because of the increased likelihood of ADR/intolerance. LEVEL OF EVIDENCE: Therapeutic Level III.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland.
- Department of Orthopaedics, University of Maryland Medical Center, Baltimore, Maryland.
- Department of Orthopaedic Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Zitieren
APA
Nandi, S., Doub, J. B., De Palma, B. J., Potter, G. R., Stronach, B. M., Stambough, J. B., Brilliant, Z. R., & Mears, S. C. (2024). Suppressive Antibiotic Therapy After Debridement, Antibiotics, and Implant Retention is Well-Tolerated Without Inducing Resistance: A Multicenter Study. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2023.09.004
Vancouver
Nandi S, Doub JB, De Palma BJ, Potter GR, Stronach BM, Stambough JB, et al. Suppressive Antibiotic Therapy After Debridement, Antibiotics, and Implant Retention is Well-Tolerated Without Inducing Resistance: A Multicenter Study. The Journal of Arthroplasty. 2024. doi:10.1016/j.arth.2023.09.004
BibTeX
@article{Nandi2024,
author = {Nandi, Sumon and Doub, James B and De Palma, Brian J and Potter, Genna R and Stronach, Benjamin M and Stambough, Jeffrey B and Brilliant, Zachary R and Mears, Simon C},
title = {Suppressive Antibiotic Therapy After Debridement, Antibiotics, and Implant Retention is Well-Tolerated Without Inducing Resistance: A Multicenter Study},
journal = {The Journal of Arthroplasty},
year = {2024},
doi = {10.1016/j.arth.2023.09.004}
}
EUVIMED